Literature DB >> 20371344

Macrophage diversity enhances tumor progression and metastasis.

Bin-Zhi Qian1, Jeffrey W Pollard.   

Abstract

There is persuasive clinical and experimental evidence that macrophages promote cancer initiation and malignant progression. During tumor initiation, they create an inflammatory environment that is mutagenic and promotes growth. As tumors progress to malignancy, macrophages stimulate angiogenesis, enhance tumor cell migration and invasion, and suppress antitumor immunity. At metastatic sites, macrophages prepare the target tissue for arrival of tumor cells, and then a different subpopulation of macrophages promotes tumor cell extravasation, survival, and subsequent growth. Specialized subpopulations of macrophages may represent important new therapeutic targets. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20371344      PMCID: PMC4994190          DOI: 10.1016/j.cell.2010.03.014

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  128 in total

1.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

Authors:  Subhra K Biswas; Lisa Gangi; Saki Paul; Tiziana Schioppa; Alessandra Saccani; Marina Sironi; Barbara Bottazzi; Andrea Doni; Bronte Vincenzo; Fabio Pasqualini; Luca Vago; Manuela Nebuloni; Alberto Mantovani; Antonio Sica
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

2.  The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2.

Authors:  H J M A A Zijlmans; G J Fleuren; H J Baelde; P H C Eilers; G G Kenter; A Gorter
Journal:  J Pathol       Date:  2006-03       Impact factor: 7.996

3.  p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.

Authors:  Alessandra Saccani; Tiziana Schioppa; Chiara Porta; Subhra K Biswas; Manuela Nebuloni; Luca Vago; Barbara Bottazzi; Mario P Colombo; Alberto Mantovani; Antonio Sica
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

4.  The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence.

Authors:  Katsuhiro Tanaka; Junichi Kurebayashi; Mai Sohda; Tsunehisa Nomura; Uma Prabhakar; Li Yan; Hiroshi Sonoo
Journal:  Thyroid       Date:  2009-01       Impact factor: 6.568

5.  IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.

Authors:  Vasilena Gocheva; Hao-Wei Wang; Bedrick B Gadea; Tanaya Shree; Karen E Hunter; Alfred L Garfall; Tara Berman; Johanna A Joyce
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

6.  The macrophage colony-stimulating factor 1 response signature in breast carcinoma.

Authors:  Andrew H Beck; Inigo Espinosa; Badreddin Edris; Rui Li; Kelli Montgomery; Shirley Zhu; Sushama Varma; Robert J Marinelli; Matt van de Rijn; Robert B West
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

7.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

Review 8.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

9.  Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.

Authors:  Shu Wang; Yuhui Yuan; Lan Liao; Shao-Qing Kuang; Jean Ching-Yi Tien; Bert W O'Malley; Jianming Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-24       Impact factor: 11.205

10.  Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.

Authors:  Jiasen Cheng; De-Hua Huo; Dong-Ming Kuang; Jine Yang; Limin Zheng; Shi-Mei Zhuang
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

View more
  1795 in total

Review 1.  Immunological basis in the pathogenesis and treatment of bladder cancer.

Authors:  David B Thompson; Larry E Siref; Michael P Feloney; Ralph J Hauke; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2014-11-13       Impact factor: 4.473

Review 2.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

3.  STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy.

Authors:  Lekh N Dahal; Lang Dou; Khiyam Hussain; Rena Liu; Alexander Earley; Kerry L Cox; Salome Murinello; Ian Tracy; Francesco Forconi; Andrew J Steele; Patrick J Duriez; Diego Gomez-Nicola; Jessica L Teeling; Martin J Glennie; Mark S Cragg; Stephen A Beers
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

4.  Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma.

Authors:  Carl Ludwig Behnes; Felix Bremmer; Bernhard Hemmerlein; Arne Strauss; Philipp Ströbel; Heinz-Joachim Radzun
Journal:  Virchows Arch       Date:  2013-12-11       Impact factor: 4.064

5.  Immune chaperone gp96 drives the contributions of macrophages to inflammatory colon tumorigenesis.

Authors:  Crystal Morales; Saleh Rachidi; Feng Hong; Shaoli Sun; Xinshou Ouyang; Caroline Wallace; Yongliang Zhang; Elizabeth Garret-Mayer; Jennifer Wu; Bei Liu; Zihai Li
Journal:  Cancer Res       Date:  2013-12-09       Impact factor: 12.701

6.  Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor.

Authors:  Teresa S Kim; Michael J Cavnar; Noah A Cohen; Eric C Sorenson; Jonathan B Greer; Adrian M Seifert; Megan H Crawley; Benjamin L Green; Rachel Popow; Nagavarakishore Pillarsetty; Darren R Veach; Anson T Ku; Ferdinand Rossi; Peter Besmer; Cristina R Antonescu; Shan Zeng; Ronald P Dematteo
Journal:  Clin Cancer Res       Date:  2014-02-28       Impact factor: 12.531

Review 7.  Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.

Authors:  Katherine Venmar Bankaitis; Barbara Fingleton
Journal:  Clin Exp Metastasis       Date:  2015-09-18       Impact factor: 5.150

8.  Fundamental Principles of Cancer Biology: Does it have relevance to the perioperative period?

Authors:  Li Jiang; Alpa M Nick; Anil K Sood
Journal:  Curr Anesthesiol Rep       Date:  2015-09

9.  Monocytes/Macrophages promote vascular CXCR4 expression via the ERK pathway in hepatocellular carcinoma.

Authors:  Ya-Ming Meng; Jing Liang; Chong Wu; Jing Xu; Dan-Ni Zeng; Xing-Juan Yu; Huiheng Ning; Li Xu; Limin Zheng
Journal:  Oncoimmunology       Date:  2017-12-13       Impact factor: 8.110

10.  Nanomedicine: An iron age for cancer therapy.

Authors:  Amy Tarangelo; Scott J Dixon
Journal:  Nat Nanotechnol       Date:  2016-09-26       Impact factor: 39.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.